ClinicalTrials.Veeva

Menu
H

Humanitas Research Hospital | Department Dermatology

Research site
(Unclaimed)

Site insights

Top conditions

Top treatments

Durvalumab
Ephedrine
Etilefrine Hydrochloride
Flagyl
PXT002331
Cefuroxime
magnesium oxide
Macrogol 4000
Meropenem
Metformin

Parent organization

This site is a part of Humanitas Research Hospital

Curious how this site stacks up to its peers?

Data sourced from clinicaltrials.gov

Work at this site?

CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.

Learn more and claim site

Active trials

7 of 70 total trials

A Study to Assess a PI3Kδ Inhibitor (IOA-244) in Patients With Metastatic Cancers

The objective of study IOA-244-101 is to determine whether IOA-244 is safe and tolerable in cancer patients (Part A). In addition, the study will ass...

Active, not recruiting
Myelofibrosis
Solid Tumor, Adult
Drug: Cisplatin
Drug: Pemetrexed

The study is researching an experimental drug called dupilumab. The study is focused on participants with active eosinophilic gastritis (EoG) with or...

Enrolling
Eosinophilic Gastrointestinal Disease
Eosinophilic Gastritis
Drug: Dupilumab Dose 2
Drug: Matching Placebo

A Phase 3b research study to consolidate the data that ivosidenib is safe and effective in adult patients with previously treated, locally advanced,...

Enrolling
Cholangiocarcinoma
Drug: Ivosidenib Oral Tablet

The aim of the DYNAMITE study is to investigate the (a) acute procedural and (b) 9-month follow-up performance of DynamX Drug-Eluting Coronary Bioada...

Active, not recruiting
Coronary Artery Disease
Long Lesions Coronary Artery Disease
Device: DynamX Drug-Eluting Coronary Bioadaptor System
Locations recently updated

The purpose of this study is to evaluate the safety and performance of the Tendyne Mitral Valve System in the treatment of severe mitral regurgitatio...

Active, not recruiting
Mitral Valve Regurgitation
Device: Tendyne Mitral Valve System

Osteoarthritis (OA) is a degenerative joint disease characterised by chronic pain, degradation and loss of articular cartilage, osteophyte formation...

Enrolling
Osteoarthritis, Knee
Device: KIT BMAC AND at-SVF FIDIA

This study is a Phase III, Randomized, Controlled, Global Multicenter Study to Evaluate the Efficacy and Safety of Oral Tinengotinib versus Physician...

Enrolling
Cholangiocarcinoma
Drug: Physician's Choice
Drug: Tinengotinib 8 mg

Trial sponsors

I
H
H
U
Abbott logo
C
Daiichi Sankyo logo
E
Gilead Sciences logo
L

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems